volume 20 issue 12 pages 747-759

Rheumatology in the digital health era: status quo and quo vadis?

Publication typeJournal Article
Publication date2024-10-31
scimago Q1
wos Q1
SJR5.507
CiteScore31.3
Impact factor32.7
ISSN17594790, 17594804
Abstract
Rheumatology faces a critical shortage of health-care professionals, exacerbated by an ageing patient population and escalating costs, resulting in widening gaps in care. Exponential advances in digital health technologies (DHTs) in the past 5 years offer new opportunities to address these challenges and could contribute to overall improved health care. However, keeping pace with innovations and integrating them into clinical practice can be challenging. This Review explores the transformative potential of DHTs for rheumatology in reshaping the entire patient pathway and redefining the roles of patients and providers, and discusses the potential barriers to DHT integration. Key technologies, such as large language models, clinical decision-support systems, digital therapeutics, electronic patient-reported outcomes, digital biomarkers, robots, self-sampling devices and artificial intelligence-based scribes, can be implemented along the patient pathway. A digital-first hybrid stepped-care patient pathway could combine in-person and remote care, enabling personalized and continuous monitoring through a digital safety net. The potential benefits and risks of transforming the traditional patient–provider relationship into a digital health triad with technology are discussed. Collaborative efforts are needed to navigate the evolving digital health landscape and harness the potential of DHTs to improve rheumatology care. Digital health has the potential to improve patient care in rheumatology and alleviate strain on the health-care system. This Review explores the current status of the transition from traditional health care to a model that harnesses the potential of digital health technologies, including discussion of the main benefits and barriers.
Found 
Found 

Top-30

Journals

1
2
3
4
Rheumatology International
4 publications, 16.67%
RMD Open
2 publications, 8.33%
EULAR Rheumatology Open
2 publications, 8.33%
Rheumatology and Therapy
1 publication, 4.17%
International Journal of Rheumatic Diseases
1 publication, 4.17%
Arthritis Research and Therapy
1 publication, 4.17%
Current Opinion in Rheumatology
1 publication, 4.17%
Medicina
1 publication, 4.17%
JMIR Human Factors
1 publication, 4.17%
Pharmaceuticals
1 publication, 4.17%
Frontiers in Medicine
1 publication, 4.17%
Rheumatology
1 publication, 4.17%
Revue du Rhumatisme (Edition Francaise)
1 publication, 4.17%
Lecture Notes in Computer Science
1 publication, 4.17%
Arthritis und Rheuma
1 publication, 4.17%
Zeitschrift fur Rheumatologie
1 publication, 4.17%
Osteologie
1 publication, 4.17%
1
2
3
4

Publishers

1
2
3
4
5
6
7
8
9
Springer Nature
9 publications, 37.5%
Elsevier
3 publications, 12.5%
MDPI
2 publications, 8.33%
BMJ
2 publications, 8.33%
Georg Thieme Verlag KG
2 publications, 8.33%
Wiley
1 publication, 4.17%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 4.17%
JMIR Publications
1 publication, 4.17%
Frontiers Media S.A.
1 publication, 4.17%
Oxford University Press
1 publication, 4.17%
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 4.17%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
26
Share
Cite this
GOST |
Cite this
GOST Copy
Knitza J. et al. Rheumatology in the digital health era: status quo and quo vadis? // Nature reviews. Rheumatology. 2024. Vol. 20. No. 12. pp. 747-759.
GOST all authors (up to 50) Copy
Knitza J., Gupta L., Hügle T. Rheumatology in the digital health era: status quo and quo vadis? // Nature reviews. Rheumatology. 2024. Vol. 20. No. 12. pp. 747-759.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41584-024-01177-7
UR - https://www.nature.com/articles/s41584-024-01177-7
TI - Rheumatology in the digital health era: status quo and quo vadis?
T2 - Nature reviews. Rheumatology
AU - Knitza, Johannes
AU - Gupta, Latika
AU - Hügle, Thomas
PY - 2024
DA - 2024/10/31
PB - Springer Nature
SP - 747-759
IS - 12
VL - 20
PMID - 39482466
SN - 1759-4790
SN - 1759-4804
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Knitza,
author = {Johannes Knitza and Latika Gupta and Thomas Hügle},
title = {Rheumatology in the digital health era: status quo and quo vadis?},
journal = {Nature reviews. Rheumatology},
year = {2024},
volume = {20},
publisher = {Springer Nature},
month = {oct},
url = {https://www.nature.com/articles/s41584-024-01177-7},
number = {12},
pages = {747--759},
doi = {10.1038/s41584-024-01177-7}
}
MLA
Cite this
MLA Copy
Knitza, Johannes, et al. “Rheumatology in the digital health era: status quo and quo vadis?.” Nature reviews. Rheumatology, vol. 20, no. 12, Oct. 2024, pp. 747-759. https://www.nature.com/articles/s41584-024-01177-7.